Cost of medication-related problems at a university hospital

Philip J Schneider, M. G. Gift, Y. P. Lee, E. A. Rothermich, B. E. Sill

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

The cost to an institution of medication-related problems (MRPs) was studied. A retrospective chart review covering the period from July 1992 through June 1994 was performed for patients at a university-affiliated medical center hospital who were known to have had clinical consequences from an adverse drug reaction (ADR) or medication error. All interventions resulting directly from the problem were recorded. A detailed list of patient charges was reviewed for each patient, and specific charges for the MRP- associated interventions were tabulated. The clinical outcomes used to evaluate intervention costs were categorized as extra laboratory tests, noninvasive procedures, additional treatments, invasive monitoring or procedures, increased length of stay, and intensive care. The cost of each intervention was calculated by applying the cost-to-charge ratio used in the institution's patient-charge-based accounting system. A total of 109 patient charts were reviewed. A total of 349 clinical outcomes associated with MRPs, or an average of 3 outcomes per patient, were detected. The mean ± S.E. cost of MRP-associated clinical outcomes to the institution ranged from $95 ± 11 for additional laboratory tests to $2640 ± 596 for intensive care. The next most costly outcomes were increased length of stay and invasive monitoring or procedures. For the 1911 MRPs reported in 1994, the estimated total cost was almost $1.5 million. A review of the medical records of patients for whom an ADR or medication error had been recorded showed a high cost of these events to the institution, with the cost varying with clinical outcome, and a correspondingly strong opportunity for pharmacists to intervene to save money and improve the quality of care.

Original languageEnglish (US)
Pages (from-to)2415-2418
Number of pages4
JournalAmerican Journal of Health-System Pharmacy
Volume52
Issue number21
StatePublished - 1995
Externally publishedYes

Fingerprint

Costs and Cost Analysis
Medication Errors
Critical Care
Drug-Related Side Effects and Adverse Reactions
Length of Stay
Quality of Health Care
Pharmacists
Medical Records
Therapeutics

Keywords

  • Costs
  • Drugs, adverse reactions
  • Errors, medication
  • Hospitals
  • Tests, laboratory
  • Toxicity

ASJC Scopus subject areas

  • Leadership and Management
  • Pharmaceutical Science

Cite this

Schneider, P. J., Gift, M. G., Lee, Y. P., Rothermich, E. A., & Sill, B. E. (1995). Cost of medication-related problems at a university hospital. American Journal of Health-System Pharmacy, 52(21), 2415-2418.

Cost of medication-related problems at a university hospital. / Schneider, Philip J; Gift, M. G.; Lee, Y. P.; Rothermich, E. A.; Sill, B. E.

In: American Journal of Health-System Pharmacy, Vol. 52, No. 21, 1995, p. 2415-2418.

Research output: Contribution to journalArticle

Schneider, PJ, Gift, MG, Lee, YP, Rothermich, EA & Sill, BE 1995, 'Cost of medication-related problems at a university hospital', American Journal of Health-System Pharmacy, vol. 52, no. 21, pp. 2415-2418.
Schneider, Philip J ; Gift, M. G. ; Lee, Y. P. ; Rothermich, E. A. ; Sill, B. E. / Cost of medication-related problems at a university hospital. In: American Journal of Health-System Pharmacy. 1995 ; Vol. 52, No. 21. pp. 2415-2418.
@article{334f51626f324a83b85d22786d3c32ca,
title = "Cost of medication-related problems at a university hospital",
abstract = "The cost to an institution of medication-related problems (MRPs) was studied. A retrospective chart review covering the period from July 1992 through June 1994 was performed for patients at a university-affiliated medical center hospital who were known to have had clinical consequences from an adverse drug reaction (ADR) or medication error. All interventions resulting directly from the problem were recorded. A detailed list of patient charges was reviewed for each patient, and specific charges for the MRP- associated interventions were tabulated. The clinical outcomes used to evaluate intervention costs were categorized as extra laboratory tests, noninvasive procedures, additional treatments, invasive monitoring or procedures, increased length of stay, and intensive care. The cost of each intervention was calculated by applying the cost-to-charge ratio used in the institution's patient-charge-based accounting system. A total of 109 patient charts were reviewed. A total of 349 clinical outcomes associated with MRPs, or an average of 3 outcomes per patient, were detected. The mean ± S.E. cost of MRP-associated clinical outcomes to the institution ranged from $95 ± 11 for additional laboratory tests to $2640 ± 596 for intensive care. The next most costly outcomes were increased length of stay and invasive monitoring or procedures. For the 1911 MRPs reported in 1994, the estimated total cost was almost $1.5 million. A review of the medical records of patients for whom an ADR or medication error had been recorded showed a high cost of these events to the institution, with the cost varying with clinical outcome, and a correspondingly strong opportunity for pharmacists to intervene to save money and improve the quality of care.",
keywords = "Costs, Drugs, adverse reactions, Errors, medication, Hospitals, Tests, laboratory, Toxicity",
author = "Schneider, {Philip J} and Gift, {M. G.} and Lee, {Y. P.} and Rothermich, {E. A.} and Sill, {B. E.}",
year = "1995",
language = "English (US)",
volume = "52",
pages = "2415--2418",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "21",

}

TY - JOUR

T1 - Cost of medication-related problems at a university hospital

AU - Schneider, Philip J

AU - Gift, M. G.

AU - Lee, Y. P.

AU - Rothermich, E. A.

AU - Sill, B. E.

PY - 1995

Y1 - 1995

N2 - The cost to an institution of medication-related problems (MRPs) was studied. A retrospective chart review covering the period from July 1992 through June 1994 was performed for patients at a university-affiliated medical center hospital who were known to have had clinical consequences from an adverse drug reaction (ADR) or medication error. All interventions resulting directly from the problem were recorded. A detailed list of patient charges was reviewed for each patient, and specific charges for the MRP- associated interventions were tabulated. The clinical outcomes used to evaluate intervention costs were categorized as extra laboratory tests, noninvasive procedures, additional treatments, invasive monitoring or procedures, increased length of stay, and intensive care. The cost of each intervention was calculated by applying the cost-to-charge ratio used in the institution's patient-charge-based accounting system. A total of 109 patient charts were reviewed. A total of 349 clinical outcomes associated with MRPs, or an average of 3 outcomes per patient, were detected. The mean ± S.E. cost of MRP-associated clinical outcomes to the institution ranged from $95 ± 11 for additional laboratory tests to $2640 ± 596 for intensive care. The next most costly outcomes were increased length of stay and invasive monitoring or procedures. For the 1911 MRPs reported in 1994, the estimated total cost was almost $1.5 million. A review of the medical records of patients for whom an ADR or medication error had been recorded showed a high cost of these events to the institution, with the cost varying with clinical outcome, and a correspondingly strong opportunity for pharmacists to intervene to save money and improve the quality of care.

AB - The cost to an institution of medication-related problems (MRPs) was studied. A retrospective chart review covering the period from July 1992 through June 1994 was performed for patients at a university-affiliated medical center hospital who were known to have had clinical consequences from an adverse drug reaction (ADR) or medication error. All interventions resulting directly from the problem were recorded. A detailed list of patient charges was reviewed for each patient, and specific charges for the MRP- associated interventions were tabulated. The clinical outcomes used to evaluate intervention costs were categorized as extra laboratory tests, noninvasive procedures, additional treatments, invasive monitoring or procedures, increased length of stay, and intensive care. The cost of each intervention was calculated by applying the cost-to-charge ratio used in the institution's patient-charge-based accounting system. A total of 109 patient charts were reviewed. A total of 349 clinical outcomes associated with MRPs, or an average of 3 outcomes per patient, were detected. The mean ± S.E. cost of MRP-associated clinical outcomes to the institution ranged from $95 ± 11 for additional laboratory tests to $2640 ± 596 for intensive care. The next most costly outcomes were increased length of stay and invasive monitoring or procedures. For the 1911 MRPs reported in 1994, the estimated total cost was almost $1.5 million. A review of the medical records of patients for whom an ADR or medication error had been recorded showed a high cost of these events to the institution, with the cost varying with clinical outcome, and a correspondingly strong opportunity for pharmacists to intervene to save money and improve the quality of care.

KW - Costs

KW - Drugs, adverse reactions

KW - Errors, medication

KW - Hospitals

KW - Tests, laboratory

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0028849879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028849879&partnerID=8YFLogxK

M3 - Article

C2 - 8564605

AN - SCOPUS:0028849879

VL - 52

SP - 2415

EP - 2418

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 21

ER -